RxDoctor Payments Data

Ariella Lee Martin

Family · Rolla, MONPI 1497278378

Payments from drug & device makers

$2,004in general payments, 2019–2025

Across 104 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$266
  • AbbVie$265
  • Lilly USA, LLC$211
  • AstraZeneca$211
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$136
  • Amgen$128
  • plus $787 from 26 others

What the payments were for

  • Food & beverage$2,004100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,004 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide90$101,451
OzempicSemaglutide50$46,962
JardianceEmpagliflozin40$39,792
TrulicityDulaglutide36$39,557
JanumetSitagliptin Phos/Metformin Hcl28$23,617
XareltoRivaroxaban29$20,690
JanuviaSitagliptin Phosphate23$18,759
FarxigaDapagliflozin Propanediol14$13,493
Tresiba Flextouch U-200Insulin Degludec19$10,954
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$8,353
VascepaIcosapent Ethyl24$8,100
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,377
MyrbetriqMirabegron13$5,242
TegretolCarbamazepine13$3,228
SynthroidLevothyroxine Sodium30$2,523

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$211$141,008126 claims
Novo NordiskOzempic$266$46,96250 claims
MerckJanumet, Januvia$16$42,37551 claims
AstraZenecaFarxiga$211$13,49314 claims
GSKTrelegy Ellipta$33$7,37711 claims
Astellas Pharma US IncMyrbetriq$16$5,24213 claims
AbbVieSynthroid$265$2,52330 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Rolla

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →